Community lists
चयनित · स्वास्थ्य सेवा

Big pharma

InspectStocks द्वाराPublished 14 अक्टू॰ 202613 companies0 follower

The largest drugmakers, selling prescription medicines worldwide.

एक AI मॉडल की मदद से समूहबद्ध और हमारे संपादकों द्वारा जाँचा गया। हर कंपनी के नीचे की पंक्ति बताती है कि वह यहाँ क्यों है।

Sign in to followSign in to copy
Download image
कार्डस्तर

शेयर मूल्य 11 नव॰ 2026 के समापन मूल्य हैं, IEX एक्सचेंज फ़ीड से।

Grade mix

A 7B 3C 3

Revenue growing

12 of 12

Free cash flow growing

9 of 13

Median price move, 1 year

+34.0%

  • LLYELI LILLY AND COMPANY

    Drug manufacturers generalMarket cap $1.35TP/E 46.67

    $1,437.79+42.2%1Y

    Since added +23.2%

    A+
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business trend
    स्थिर
    Business quality
    मज़बूत
    Getting better
    सुधर रही है

    Revenue

    $86.5B+45.5%

    Profit

    $27.6B+49.8%

    Free cash flow

    $19.7B+112.1%
    Discuss
    Why it is here: Sells prescription medicines for diabetes, obesity, cancer and inflammation
  • JNJJohnson & Johnson

    Drug manufacturers generalMarket cap $674.9BP/E 42.54

    $280.34+47.5%1Y

    Since added +12.8%

    A+
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business trend
    स्थिर
    Business quality
    मज़बूत
    Getting better
    मिश्रित

    Revenue

    $99.3B+7.8%

    Profit

    $16.1B-35.9%

    Free cash flow

    $20.6B+5.1%
    Discuss
    Why it is here: Sells prescription medicines for cancer and immune disorders
  • ABBVAbbVie Inc.

    Drug manufacturers generalMarket cap $521.2BP/E 50.75

    $294.87+30.2%1Y

    Since added +7.5%

    B+
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business trend
    स्थिर
    Business quality
    मज़बूत
    Getting better
    सुधर रही है

    Revenue

    $66B+10.7%

    Profit

    $10.3B+333.1%

    Free cash flow

    $18.9B-4.1%
    Discuss
    Why it is here: Sells medicines for immune, neurological and cancer conditions
  • MRKMerck & Co., Inc.

    Drug manufacturers generalMarket cap $362.9BP/E 150.20

    $147.20+65.7%1Y

    Since added +3.7%

    A
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business trend
    स्थिर
    Business quality
    ठोस
    Getting better
    मिश्रित

    Revenue

    $67.4B+4.9%

    Profit

    $2.5B-87.1%

    Free cash flow

    $14.7B+13.0%
    Discuss
    Why it is here: Sells prescription medicines and vaccines for people and animals
  • NVSNovartis AG

    Drug manufacturers generalMarket cap $306BP/E नहीं (परिचालन घाटा)

    $160.36+23.6%1Y

    Since added +12.6%

    A
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business quality
    मिश्रित
    Getting better
    तेज़ी से सुधर रही है

    Revenue

    $56.7B+9.6%

    Profit

    -$46MNo comparable year

    Free cash flow

    $17.6B+8.3%
    Discuss
    Why it is here: Sells prescription medicines
  • AZNASTRAZENECA PLC

    Drug manufacturers generalMarket cap $289.7BP/E 28.36

    $185.49+115.2%1Y

    Since added +19.0%

    B+
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business trend
    धीमा हो रहा
    Business quality
    मज़बूत
    Getting better
    तेज़ी से सुधर रही है

    Revenue

    $62.4B+7.3%

    Profit

    $10.2B+45.3%

    Free cash flow

    $11.8B+18.4%
    Discuss
    Why it is here: Sells prescription medicines
  • NVONOVO NORDISK A/S

    Drug manufacturers generalMarket cap $182.8BP/E 11.84

    $41.10-15.4%1Y

    Since added +8.0%

    C+
    वृद्धि और नकदी
    बढ़ रही है
    Business trend
    तेज़ हो रहा
    Business quality
    मज़बूत
    Getting better
    सुधर रही है

    Revenue

    $50.3B+5.7%

    Profit

    $17.1B+9.1%

    Free cash flow

    $8.9B-20.1%
    Discuss
    Why it is here: Sells diabetes and obesity medicines
  • PFEPFIZER INC

    Drug manufacturers generalMarket cap $167.9BP/E 42.07

    $29.45+21.4%1Y

    Since added +3.8%

    C
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business trend
    सिकुड़ रहा
    Business quality
    ठोस
    Getting better
    मिश्रित

    Revenue

    $63.6B+1.3%

    Profit

    $4B-59.0%

    Free cash flow

    $11.8B+13.6%
    Discuss
    Why it is here: Sells prescription medicines and vaccines
  • BMYBRISTOL-MYERS SQUIBB COMPANY

    Drug manufacturers generalMarket cap $128.6BP/E 13.95

    $62.92+34.0%1Y

    Since added +11.0%

    C+
    वृद्धि और नकदी
    बढ़ रही है
    Business trend
    स्थिर
    Business quality
    मज़बूत
    Getting better
    तेज़ी से सुधर रही है

    Revenue

    $50B+4.2%

    Profit

    $9.2B+53.1%

    Free cash flow

    $9.3B-39.3%
    Discuss
    Why it is here: Sells prescription medicines for cancer and immune conditions
  • SNYSanofi

    Drug manufacturers generalMarket cap $59.1BP/E 6.81

    $48.43-3.0%1Y

    Since added +23.9%

    B
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business trend
    स्थिर
    Business quality
    मिश्रित
    Getting better
    सुधर रही है

    Revenue

    $53.5B+11.6%

    Profit

    $4.7B-54.2%

    Free cash flow

    $8.1B+22.5%
    Discuss
    Why it is here: Sells prescription medicines and vaccines
  • GSKGSK plc

    Drug manufacturers generalMarket cap $109.2BP/E 13.60

    $50.60+8.9%1Y

    Since added +9.3%

    A+
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business quality
    मज़बूत
    Getting better
    तेज़ी से सुधर रही है

    Revenue

    $43.8B+4.1%

    Profit

    $7.7B+122.0%

    Free cash flow

    $8.6B+24.0%
    Discuss
    Why it is here: Sells prescription medicines and vaccines worldwide
  • AMGNAmgen Inc.

    Drug manufacturers generalMarket cap $253.2BP/E 27.14

    $468.13+43.1%1Y

    Since added +13.4%

    A+
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business trend
    स्थिर
    Business quality
    मज़बूत
    Getting better
    सुधर रही है

    Revenue

    $38.9B+8.2%

    Profit

    $9.4B+34.1%

    Free cash flow

    $9.6B-17.0%
    Discuss
    Why it is here: Develops and sells medicines and biosimilars for serious diseases
  • TAKTakeda Pharmaceutical Company Limited

    Drug manufacturers specialty and genericMarket cap $33.5BP/E 48.79

    $20.86+50.1%1Y

    Since added +12.5%

    A
    वृद्धि और नकदी
    मज़बूती से बढ़ रही है
    Business quality
    मिश्रित
    Getting better
    मिश्रित

    Revenue

    $29.8BNo comparable year

    Profit

    $259.4MNo comparable year

    Free cash flow

    $5.5B+1.1%
    Discuss
    Why it is here: Sells prescription medicines and vaccines globally

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.